The initial success of Viagra undeniably revolutionized the medication landscape, but betting in companies heavily reliant on off-patent versions presents a challenging picture. Although early returns were substantial, the cessation of patents and the rise of cheaper alternatives have eroded sales. Therefore, a thorough assessment of ongoing income